Wei Xu

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 66

Top Topics

Chronic Lymphocytic Leukemia

Diffuse Large B Cell Lymphoma

Prognostic Factors

Top Venues

Annals of hematology

British journal of haematology

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ziwen Duan, Xiao Zhang, Yanping Liu, Jiawen Wang, Han Zhu, Ruize Chen, Wei Xu, Kourong Miao
The impact of matched and mismatched donor-recipient genotypes for MDR1 polymorphisms (G2677TA, C1236T and C3435T) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation. British journal of haematology (2024)
Li-Ye Bei, Chun-Yu Shang, Jia-Zhu Wu, Hao-Rui Shen, Hua Yin, Jin-Hua Liang, Xin-Yu Zhang, Li Wang, Jian-Yong Li, Yue Li, Wei Xu
Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century. Annals of hematology 103 (5) (2024)
Li-Ye Bei, Chun-Yu Shang, Jia-Zhu Wu, Hao-Rui Shen, Hua Yin, Jin-Hua Liang, Xin-Yu Zhang, Li Wang, Jian-Yong Li, Yue Li, Wei Xu
Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century. Annals of hematology (2024)
Shuangshuang Xing, Yiqin Pu, Xiaoqian Zhao, Yan Hu, Feiyan Zhang, Zejuan Gu, Wei Xu, Lei Fan, Yi Miao, Jian-Yong Li
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 57 (2024)
Li-Ye Bei, Chun-Yu Shang, Jia-Zhu Wu, Hao-Rui Shen, Hua Yin, Jin-Hua Liang, Xin-Yu Zhang, Li Wang, Jian-Yong Li, Yue Li, Wei Xu
Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century. Annals of hematology 103 (5) (2024)
Kai-Xin Du, Yi-Fan Wu, Wei Hua, Zi-Wen Duan, Rui Gao, Jun-Heng Liang, Yue Li, Hua Yin, Jia-Zhu Wu, Hao-Rui Shen, Li Wang, Yang Shao, Jian-Yong Li, Jin-Hua Liang, Wei Xu
Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms. Cell communication and signaling : CCS 22 (1) (2024)
Shuangshuang Xing, Yiqin Pu, Xiaoqian Zhao, Yan Hu, Feiyan Zhang, Zejuan Gu, Wei Xu, Lei Fan, Yi Miao, Jian-Yong Li
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 57 (2024)
Jin-Hua Liang, Yi-Fan Wu, Hao-Rui Shen, Yue Li, Jun-Heng Liang, Rui Gao, Wei Hua, Chun-Yu Shang, Kai-Xin Du, Tong-Yao Xing, Xin-Yu Zhang, Chen-Xuan Wang, Liu-Qing Zhu, Yang W Shao, Jian-Yong Li, Jia-Zhu Wu, Hua Yin, Li Wang, Wei Xu
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma. Leukemia 38 (7) (2024)
Li-Ye Bei, Chun-Yu Shang, Jia-Zhu Wu, Hao-Rui Shen, Hua Yin, Jin-Hua Liang, Xin-Yu Zhang, Li Wang, Jian-Yong Li, Yue Li, Wei Xu
Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century. Annals of hematology 103 (5) (2024)
Ziwen Duan, Xiao Zhang, Yanping Liu, Jiawen Wang, Han Zhu, Ruize Chen, Wei Xu, Kourong Miao
The impact of matched and mismatched donor-recipient genotypes for MDR1 polymorphisms (G2677TA, C1236T and C3435T) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation. British journal of haematology 205 (2) (2024)
Shuangshuang Xing, Yiqin Pu, Xiaoqian Zhao, Yan Hu, Feiyan Zhang, Zejuan Gu, Wei Xu, Lei Fan, Yi Miao, Jian-Yong Li
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 57 (2024)
Yan Gao, Haixia He, Xueping Li, Liling Zhang, Wei Xu, Ru Feng, Wenyu Li, Yin Xiao, Xinxiu Liu, Yu Chen, Xiaoxiao Wang, Bing Bai, Huijing Wu, Qing-Qing Cai, Zhi-Ming Li, Weiwei Xiao, Suxia Lin, Yanxia He, Liqin Ping, Cheng Huang, Jiaying Mao, Xiujin Chen, Baitian Zhao, Huiqiang Huang
Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study. Signal transduction and targeted therapy 9 (1) (2024)
Yan Gao, Haixia He, Xueping Li, Liling Zhang, Wei Xu, Ru Feng, Wenyu Li, Yin Xiao, Xinxiu Liu, Yu Chen, Xiaoxiao Wang, Bing Bai, Huijing Wu, Qing-Qing Cai, Zhi-Ming Li, Weiwei Xiao, Suxia Lin, Yanxia He, Liqin Ping, Cheng Huang, Jiaying Mao, Xiujin Chen, Baitian Zhao, Huiqiang Huang
Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study. Signal transduction and targeted therapy 9 (1) (2024)
Yan Gao, Haixia He, Xueping Li, Liling Zhang, Wei Xu, Ru Feng, Wenyu Li, Yin Xiao, Xinxiu Liu, Yu Chen, Xiaoxiao Wang, Bing Bai, Huijing Wu, Qing-Qing Cai, Zhi-Ming Li, Weiwei Xiao, Suxia Lin, Yanxia He, Liqin Ping, Cheng Huang, Jiaying Mao, Xiujin Chen, Baitian Zhao, Huiqiang Huang
Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study. Signal transduction and targeted therapy 9 (1) (2024)
Jin-Hua Liang, Yi-Fan Wu, Hao-Rui Shen, Yue Li, Jun-Heng Liang, Rui Gao, Wei Hua, Chun-Yu Shang, Kai-Xin Du, Tong-Yao Xing, Xin-Yu Zhang, Chen-Xuan Wang, Liu-Qing Zhu, Yang W Shao, Jian-Yong Li, Jia-Zhu Wu, Hua Yin, Li Wang, Wei Xu
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma. Leukemia 38 (7) (2024)
Ziwen Duan, Xiao Zhang, Yanping Liu, Jiawen Wang, Han Zhu, Ruize Chen, Wei Xu, Kourong Miao
The impact of matched and mismatched donor-recipient genotypes for MDR1 polymorphisms (G2677TA, C1236T and C3435T) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation. British journal of haematology 205 (2) (2024)
Shuangshuang Xing, Yiqin Pu, Xiaoqian Zhao, Yan Hu, Feiyan Zhang, Zejuan Gu, Wei Xu, Lei Fan, Yi Miao, Jian-Yong Li
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 57 (2024)
Kai-Xin Du, Yi-Fan Wu, Wei Hua, Zi-Wen Duan, Rui Gao, Jun-Heng Liang, Yue Li, Hua Yin, Jia-Zhu Wu, Hao-Rui Shen, Li Wang, Yang Shao, Jian-Yong Li, Jin-Hua Liang, Wei Xu
Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms. Cell communication and signaling : CCS 22 (1) (2024)
Jin-Hua Liang, Yi-Fan Wu, Hao-Rui Shen, Yue Li, Jun-Heng Liang, Rui Gao, Wei Hua, Chun-Yu Shang, Kai-Xin Du, Tong-Yao Xing, Xin-Yu Zhang, Chen-Xuan Wang, Liu-Qing Zhu, Yang W Shao, Jian-Yong Li, Jia-Zhu Wu, Hua Yin, Li Wang, Wei Xu
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma. Leukemia (2024)
Yan Gao, Haixia He, Xueping Li, Liling Zhang, Wei Xu, Ru Feng, Wenyu Li, Yin Xiao, Xinxiu Liu, Yu Chen, Xiaoxiao Wang, Bing Bai, Huijing Wu, Qing-Qing Cai, Zhi-Ming Li, Weiwei Xiao, Suxia Lin, Yanxia He, Liqin Ping, Cheng Huang, Jiaying Mao, Xiujin Chen, Baitian Zhao, Huiqiang Huang
Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study. Signal transduction and targeted therapy 9 (1) (2024)
Lian-Guo Xue, Hao-Rui Shen, Rui Gao, Kai-Xin Du, Tong-Yao Xing, Wei-Ting Wang, Li Wang, Jian-Yong Li, Jin-Hua Liang, Wei Xu
Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma. Annals of hematology (2023)
Chun-Yu Shang, Jia-Zhu Wu, Yi-Min Ren, Jin-Hua Liang, Hua Yin, Yi Xia, Li Wang, Jian-Yong Li, Yue Li, Wei Xu
Prognostic significance of absolute monocyte count and lymphocyte to monocyte ratio in mucosa-associated lymphoid tissue (MALT) lymphoma. Annals of hematology 102 (2) (2023)
Lian-Guo Xue, Hao-Rui Shen, Rui Gao, Kai-Xin Du, Tong-Yao Xing, Wei-Ting Wang, Li Wang, Jian-Yong Li, Jin-Hua Liang, Wei Xu
Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma. Annals of hematology 102 (4) (2023)
Lian-Guo Xue, Hao-Rui Shen, Rui Gao, Kai-Xin Du, Tong-Yao Xing, Wei-Ting Wang, Li Wang, Jian-Yong Li, Jin-Hua Liang, Wei Xu
Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma. Annals of hematology (2023)
Tong-Yao Xing, Zi-Wen Duan, Wei-Ting Wang, Kai-Xin Du, Hao-Rui Shen, Hua Yin, Jia-Zhu Wu, Yue Li, Li Wang, Jian-Yong Li, Jin-Hua Liang, Wei Xu
Dynamic changes in circulating EBV-DNA load during treatment have prognostic values in EBV + DLBCL-NOS: a Chinese cohort study. Annals of hematology (2023)
Chun-Yu Shang, Jia-Zhu Wu, Yi-Min Ren, Jin-Hua Liang, Hua Yin, Yi Xia, Li Wang, Jian-Yong Li, Yue Li, Wei Xu
Prognostic significance of absolute monocyte count and lymphocyte to monocyte ratio in mucosa-associated lymphoid tissue (MALT) lymphoma. Annals of hematology 102 (2) (2023)
Kai-Xin Du, Hao-Rui Shen, Bi-Hui Pan, Sibusiso Luthuli, Li Wang, Jin-Hua Liang, Yue Li, Hua Yin, Jian-Yong Li, Jia-Zhu Wu, Wei Xu
Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Yuqin Song, Ke-Shu Zhou, Dehui Zou, Dengju Li, Jian-da Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Dao-Bin Zhou, Constantine S Tam, David Simpson, Michael L Wang, Tycel J Phillips, Stephen Samuel Opat, Cheng Fang, Shaohui Sun, Jun Zhu
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis. Cancer medicine (2023)
Wenyi Li, Rui Gao, Weiting Wang, Jing Tang, Hua Yin, Jiazhu Wu, Jinhua Liang, Yue Li, Li Wang, Jianyong Li, Haorui Shen, Wei Xu
Low T3 syndrome as a predictor of poor prognosis in peripheral T-cell lymphomas. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Chun-Yu Shang, Jia-Zhu Wu, Yi-Min Ren, Jin-Hua Liang, Hua Yin, Yi Xia, Li Wang, Jian-Yong Li, Yue Li, Wei Xu
Prognostic significance of absolute monocyte count and lymphocyte to monocyte ratio in mucosa-associated lymphoid tissue (MALT) lymphoma. Annals of hematology 102 (2) (2023)
Chun-Yu Shang, Li-Ye Bei, Jia-Zhu Wu, Hao-Rui Sheng, Hua Yin, Jin-Hua Liang, Li Wang, Jian-Yong Li, Yue Li, Wei Xu
NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia. Annals of hematology (2023)
Yi Miao, Yeqin Sha, Yi Xia, Shuchao Qin, Rui Jiang, Luomengjia Dai, Hui Shen, Tonglu Qiu, Wei Wu, Jingyan Qiu, Yilian Yang, Chongyang Ding, Yujie Wu, Lei Fan, Wei Xu, Jian-Yong Li, Huayuan Zhu
Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort. Blood cancer journal 13 (1) (2023)
Lian-Guo Xue, Hao-Rui Shen, Rui Gao, Kai-Xin Du, Tong-Yao Xing, Wei-Ting Wang, Li Wang, Jian-Yong Li, Jin-Hua Liang, Wei Xu
Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma. Annals of hematology 102 (4) (2023)
Zhangdi Xu, Bihui Pan, Yue Li, Yi Xia, Jinhua Liang, Yilin Kong, Xinyu Zhang, Jing Tang, Li Wang, Jianyong Li, Wei Xu, Jiazhu Wu
Identification and Validation of Ferroptosis-Related LncRNAs Signature as a Novel Prognostic Model for Chronic Lymphocytic Leukemia. International journal of general medicine 16 (2023)
Hao-Rui Shen, Jing Tang, Wen-Yi Li, Jin-Hua Liang, Yue Li, Jia-Zhu Wu, Li Wang, Jian-Yong Li, Rui Gao, Hua Yin, Wei Xu
25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas. Annals of hematology (2023)
Chun-Yu Shang, Jia-Zhu Wu, Yi-Min Ren, Jin-Hua Liang, Hua Yin, Yi Xia, Li Wang, Jian-Yong Li, Yue Li, Wei Xu
Prognostic significance of absolute monocyte count and lymphocyte to monocyte ratio in mucosa-associated lymphoid tissue (MALT) lymphoma. Annals of hematology (2023)
Lian-Guo Xue, Hao-Rui Shen, Rui Gao, Kai-Xin Du, Tong-Yao Xing, Wei-Ting Wang, Li Wang, Jian-Yong Li, Jin-Hua Liang, Wei Xu
Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma. Annals of hematology 102 (4) (2023)
Jin-Hua Liang, Yi-Min Ren, Kai-Xin Du, Rui Gao, Zi-Wen Duan, Jing-Ran Guo, Tong-Yao Xing, Wei-Ting Wang, Li Wang, Yan Wang, Rong Wang, Jian-Yong Li, Wei Xu
MYC-induced cytidine metabolism regulates survival and drug resistance via cGas-STING pathway in mantle cell lymphoma. British journal of haematology (2023)
Zhangdi Xu, Bihui Pan, Yue Li, Yi Xia, Jinhua Liang, Yilin Kong, Xinyu Zhang, Jing Tang, Li Wang, Jianyong Li, Wei Xu, Jiazhu Wu
Identification and Validation of Ferroptosis-Related LncRNAs Signature as a Novel Prognostic Model for Chronic Lymphocytic Leukemia. International journal of general medicine 16 (2023)
Jin-Hua Liang, Wei-Ting Wang, Kai-Xin Du, Tong-Yao Xing, Yan Wang, Hui Wang, Lu Liu, Rui Guo, Yang Shao, Junheng Liang, Yue Li, Hao-Rui Shen, Li Wang, Jian-Yong Li, Wei Xu
Establishment and comprehensive analysis of a new human cell line (NK-NJ) with NK-cell characteristics established from extranodal natural killer cell lymphoma/leukemia. Human cell (2022)
Jin-Hua Liang, Wei-Ting Wang, Kai-Xin Du, Tong-Yao Xing, Yan Wang, Hui Wang, Lu Liu, Rui Guo, Yang Shao, Junheng Liang, Yue Li, Hao-Rui Shen, Li Wang, Jian-Yong Li, Wei Xu
Establishment and comprehensive analysis of a new human cell line (NK-NJ) with NK-cell characteristics established from extranodal natural killer cell lymphoma/leukemia. Human cell 36 (2) (2022)
Jin-Hua Liang, Wei-Ting Wang, Kai-Xin Du, Tong-Yao Xing, Yan Wang, Hui Wang, Lu Liu, Rui Guo, Yang Shao, Junheng Liang, Yue Li, Hao-Rui Shen, Li Wang, Jian-Yong Li, Wei Xu
Establishment and comprehensive analysis of a new human cell line (NK-NJ) with NK-cell characteristics established from extranodal natural killer cell lymphoma/leukemia. Human cell 36 (2) (2022)
Xin Cao, Yi-Lin Kong, Li Wang, Jin-Hua Liang, Yi Xia, Hua-Yuan Zhu, Lei Fan, Sheng-Hua Jiang, Hong Liu, Jian-Yong Li, Wei Xu
Circulating low CD4+/CD8+ ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients. Annals of hematology 100 (4) (2021)
Yi-Min Ren, Chun-Yu Shang, Jin-Hua Liang, Hua Yin, Yi Xia, Jia-Zhu Wu, Li Wang, Jian-Yong Li, Yue Li, Wei Xu
Prognostic significance of serum immunoglobulin paraprotein in mucosa-associated lymphoid tissue (MALT) lymphoma. British journal of haematology 196 (6) (2021)
Dan-Min Xu, Jin-Hua Liang, Li Wang, Hua-Yuan Zhu, Yi Xia, Lei Fan, Jian-Yong Li, Wei Xu
25-Hydroxy vitamin D deficiency predicts inferior prognosis in mantle cell lymphoma. Journal of cancer research and clinical oncology 146 (4) (2020)
Jin Mao, Hua Yin, Li Wang, Jia-Zhu Wu, Yi Xia, Hua-Yuan Zhu, Lei Fan, Jian-Yong Li, Jin-Hua Liang, Wei Xu
Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma. Annals of hematology 100 (2) (2020)
Wei-Ting Wang, Jin-Hua Liang, Li Wang, Hua-Yuan Zhu, Yi Xia, Lei Fan, Jian-Yong Li, Wei Xu
The prognostic value of 25-hydroxy vitamin D deficiency and its interaction with c-Myc expression in diffuse large B cell lymphoma. Annals of hematology 99 (10) (2020)
Yun-Chen Wei, Chong-Yang Ding, Jin-Hua Liang, Li Wang, Hua-Yuan Zhu, Yi Xia, Jia-Zhu Wu, Lei Fan, Tian-Nv Li, Jian-Yong Li, Wei Xu
Interim response in diffuse large B cell lymphoma on CT: what is the optimal size reduction (ΔSPD) for predicting outcome? European radiology 30 (6) (2020)
Zijuan Wu, Handong Sun, Wenjie Liu, Huayuan Zhu, Jianxin Fu, Chuang Yang, Lei Fan, Li Wang, Yanfeng Liu, Wei Xu, Jianyong Li, Hui Jin
Circ-RPL15: a plasma circular RNA as novel oncogenic driver to promote progression of chronic lymphocytic leukemia. Leukemia 34 (3) (2019)
Yi-Xin Zou, Hua-Yuan Zhu, Xiao-Tong Li, Yi Xia, Kou-Rong Miao, Si-Shu Zhao, Yu-Jie Wu, Li Wang, Wei Xu, Jian-Yong Li
The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Hematological oncology 37 (4) (2019)
Ke Shi, Qian Sun, Chun Qiao, Huayuan Zhu, Li Wang, Jiazhu Wu, Lili Wang, Jianxin Fu, Ken H Young, Lei Fan, Yi Xia, Wei Xu, Jian-Yong Li
98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia. Cancer medicine 9 (3) (2019)
Yi Miao, Xiao-Hui Zhou, Jing-Jing Guo, Qian Sun, Ke Shi, Jia-Zhu Wu, Hua-Yuan Zhu, Li Wang, Lei Fan, Wei Xu, Jian-Yong Li
Association of red blood cell distribution width and outcomes in patients with mantle cell lymphoma. Cancer medicine 8 (6) (2019)
Jin-Hua Liang, Hua-Yuan Zhu, Dan-Min Xu, Li Wang, Yan Wang, Chun Qiao, Yu-Jie Wu, Rong Wang, Jian-Yong Li, Wei Xu
A new SH2D1A mutation in a female adult XLP disease with hemophagocytic lymphohistiocytosis and NK-cell leukemia. Annals of hematology 98 (12) (2019)
Rui Gao, Jin-Hua Liang, Li Wang, Hua-Yuan Zhu, Wei Wu, Lei Cao, Lei Fan, Jian-Yong Li, Tao Yang, Wei Xu
Low serum cholesterol levels predict inferior prognosis and improve NCCN-IPI scoring in diffuse large B cell lymphoma. International journal of cancer 143 (8) (2018)
Jun-Ying Niu, Tian Tian, Hua-Yuan Zhu, Jin-Hua Liang, Wei Wu, Lei Cao, Rui-Nan Lu, Li Wang, Jian-Yong Li, Wei Xu
Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma. Annals of hematology 97 (10) (2018)
Rui Gao, Rui-Ze Chen, Yi Xia, Jin-Hua Liang, Li Wang, Hua-Yuan Zhu, Jia- Zhu Wu, Lei Fan, Jian-Yong Li, Tao Yang, Wei Xu
Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia. International journal of cancer 143 (3) (2018)
Jin-Hua Liang, Rui Gao, Jun-Cheng Dai, Robert Peter Gale, Wang Li, Lei Fan, Zhi-Bin Hu, Wei Xu, Jian-Yong Li
The prognostic role of HBV infection in chronic lymphocytic leukemia. Journal of cancer research and clinical oncology 144 (7) (2018)
Fang-Tian Wu, Luo Lu, Wei Xu, Jian-Yong Li
Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma. Annals of hematology 98 (2) (2018)
Shuchao Qin, Lei Fan, Jinhua Liang, Robert Gale, Yi Miao, Yujie Wu, Rong Wang, Hui Yang, Wei Wu, Yi Xia, Jiazhu Wu, Huayuan Zhu, Li Wang, Wei Xu, Jian-Yong Li
Definition of disease-progression risk stratification in untreated chronic lymphocytic leukemia using combined clinical, molecular and virological variables. Hematological oncology 36 (4) (2018)
Yu-Qiong Yang, Tian Tian, Hua-Yuan Zhu, Jin-Hua Liang, Wei Wu, Jia-Zhu Wu, Yi Xia, Li Wang, Lei Fan, Jian-Yong Li, Wei Xu
NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia. BMC cancer 18 (1) (2018)
Wen-Ting Wang, Hua-Yuan Zhu, Yu-Jie Wu, Yi Xia, Jia-Zhu Wu, Wei Wu, Jin-Hua Liang, Li Wang, Lei Fan, Jian-Yong Li, Wei Xu
Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia. Journal of cancer research and clinical oncology 144 (3) (2018)
Yixin Zou, Lei Fan, Yi Xia, Yi Miao, Wei Wu, Lei Cao, Jiazhu Wu, Huayuan Zhu, Chun Qiao, Li Wang, Wei Xu, Jian-Yong Li
NOTCH1 mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases. Cancer medicine 7 (5) (2018)
Ying-Ying Yuan, Hua-Yuan Zhu, Jia-Zhu Wu, Yi Xia, Jin-Hua Liang, Wei Wu, Lei Cao, Li Wang, Lei Fan, Jian-Yong Li, Wei Xu
The percentage of cells with 17p deletion and the size of 17p deletion subclones show prognostic significance in chronic lymphocytic leukemia. Genes, chromosomes & cancer 58 (1) (2018)
Xin-Yu Zhang, Jin-Hua Liang, Li Wang, Hua-Yuan Zhu, Wei Wu, Lei Cao, Lei Fan, Jian-Yong Li, Wei Xu
DA-EPOCH-R improves the outcome over that of R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high-risk IPI, but not for double expressor lymphoma. Journal of cancer research and clinical oncology 145 (1) (2018)
Yue Li, Li Wang, Hua-Yuan Zhu, Jin-Hua Liang, Wei Wu, Jia-Zhu Wu, Yi Xia, Lei Fan, Jian-Yong Li, Wei Xu
Prognostic significance of serum immunoglobulin paraprotein in patients with diffuse large B cell lymphoma. British journal of haematology 182 (1) (2017)
Rui Gao, Jin-Hua Liang, Li Wang, Hua-Yuan Zhu, Wei Wu, Jia-Zhu Wu, Yi Xia, Lei Cao, Lei Fan, Tao Yang, Jian-Yong Li, Wei Xu
Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma. British journal of haematology 177 (1) (2017)